LIMITLESS: Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets (clinicaltrials.gov) - Oct 14, 2026 - P3 | N=96 | Recruiting | Sponsor: InSightec | N=30 ➔ 96 | Trial completion date: Dec 2027 ➔ Dec 2031 | Trial primary completion date: Jun 2027 ➔ Jun 2031
Enrollment change • Trial completion date • Trial primary completion date • Brain Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|